Skip to content

Study on the application of skin care ointment containing Oligomaltose X in controlling eczema pruritus

Study on the application of skin care ointment containing Oligomaltose X in controlling eczema pruritus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041586
Enrollment
Unknown
Registered
2020-12-31
Start date
2021-01-11
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema

Interventions

Experimental group:Skin care ointment
Control group:Skin care control ointment

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with mild or moderate eczema aged over 18 years; 2. Patients with local skin pruritus; 3. Patients with itchy skin without damage; 4. Patients without allergic history; 5. Subjects who did not use other skin plasters 2 days before enrollment; 6. Subjects who did not use oral anti-inflammatory and anti allergic drugs; 7. Subjects who agreed to the treatment specified in the protocol; 8. subjects who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with definite skin infection; 2. Subjects with speech communication disorder; 3. Patients with skin ulceration (those with pruritus at non ulceration sites can be selected, but the medical devices in this study should not be used at ulceration sites); 4. The subjects who used the medical device in this test and did not use other skin smearing drugs or medical devices (the treatment of ulceration site was in accordance with the doctor's advice) at the same time; 5. According to the judgment of the researchers, there are other situations that are not suitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
EASI;

Countries

China

Contacts

Public ContactLinfeng Li

Beijing Friendship Hospital Affiliated to Capital Medical University

zoonli@sina.com+86 13693620186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026